Annual Cash & Cash Equivalents
$28.40 M
-$15.08 M-34.69%
December 31, 2023
Summary
- As of March 9, 2025, DRRX annual cash & cash equivalents is $28.40 million, with the most recent change of -$15.08 million (-34.69%) on December 31, 2023.
- During the last 3 years, DRRX annual cash & cash equivalents has risen by +$7.09 million (+33.26%).
- DRRX annual cash & cash equivalents is now -56.67% below its all-time high of $65.54 million, reached on December 31, 2005.
Performance
DRRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$9.09 M
-$6.56 M-41.93%
September 30, 2024
Summary
- As of March 9, 2025, DRRX quarterly cash and cash equivalents is $9.09 million, with the most recent change of -$6.56 million (-41.93%) on September 30, 2024.
- Over the past year, DRRX quarterly cash and cash equivalents has dropped by -$29.90 million (-76.69%).
- DRRX quarterly cash and cash equivalents is now -86.14% below its all-time high of $65.54 million, reached on December 31, 2005.
Performance
DRRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
DRRX Cash And Cash Equivalents Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -34.7% | -76.7% |
3 y3 years | +33.3% | -83.6% |
5 y5 years | -10.3% | -77.1% |
DRRX Cash And Cash Equivalents Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -43.0% | at low | -82.0% | at low |
5 y | 5-year | -43.0% | +33.3% | -84.2% | at low |
alltime | all time | -56.7% | +959.7% | -86.1% | +361.2% |
DURECT Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $9.09 M(-41.9%) |
Jun 2024 | - | $15.65 M(-18.7%) |
Mar 2024 | - | $19.25 M(-32.2%) |
Dec 2023 | $28.40 M(-34.7%) | $28.40 M(-27.2%) |
Sep 2023 | - | $38.98 M(+22.7%) |
Jun 2023 | - | $31.76 M(-19.2%) |
Mar 2023 | - | $39.30 M(-9.6%) |
Dec 2022 | $43.48 M(-12.8%) | $43.48 M(-13.7%) |
Sep 2022 | - | $50.39 M(+6.9%) |
Jun 2022 | - | $47.13 M(-4.7%) |
Mar 2022 | - | $49.44 M(-0.8%) |
Dec 2021 | $49.84 M(+133.9%) | $49.84 M(-10.0%) |
Sep 2021 | - | $55.41 M(-1.2%) |
Jun 2021 | - | $56.07 M(-2.6%) |
Mar 2021 | - | $57.55 M(+170.0%) |
Dec 2020 | $21.31 M(-39.0%) | $21.31 M(+14.2%) |
Sep 2020 | - | $18.67 M(+1.2%) |
Jun 2020 | - | $18.45 M(-43.4%) |
Mar 2020 | - | $32.58 M(-6.7%) |
Dec 2019 | $34.92 M(+10.4%) | $34.92 M(-12.1%) |
Sep 2019 | - | $39.73 M(+7.5%) |
Jun 2019 | - | $36.94 M(+33.7%) |
Mar 2019 | - | $27.64 M(-12.7%) |
Dec 2018 | $31.64 M(+7.7%) | $31.64 M(-17.2%) |
Sep 2018 | - | $38.22 M(+2.4%) |
Jun 2018 | - | $37.34 M(-5.1%) |
Mar 2018 | - | $39.33 M(+33.9%) |
Dec 2017 | $29.38 M(+443.6%) | $29.38 M(-16.8%) |
Sep 2017 | - | $35.29 M(+16.1%) |
Jun 2017 | - | $30.41 M(+611.7%) |
Mar 2017 | - | $4.27 M(-20.9%) |
Dec 2016 | $5.40 M(+50.8%) | $5.40 M(+0.8%) |
Sep 2016 | - | $5.36 M(-33.3%) |
Jun 2016 | - | $8.04 M(+108.6%) |
Mar 2016 | - | $3.85 M(+7.5%) |
Dec 2015 | $3.58 M(+33.7%) | $3.58 M(-33.5%) |
Sep 2015 | - | $5.39 M(-10.0%) |
Jun 2015 | - | $5.99 M(+201.2%) |
Mar 2015 | - | $1.99 M(-25.8%) |
Dec 2014 | $2.68 M(-65.8%) | $2.68 M(-21.7%) |
Sep 2014 | - | $3.42 M(-81.7%) |
Jun 2014 | - | $18.67 M(+847.9%) |
Mar 2014 | - | $1.97 M(-74.9%) |
Dec 2013 | $7.84 M(-30.0%) | $7.84 M(-18.0%) |
Sep 2013 | - | $9.56 M(+19.6%) |
Jun 2013 | - | $7.99 M(-3.2%) |
Mar 2013 | - | $8.25 M(-26.3%) |
Dec 2012 | $11.20 M | $11.20 M(+78.1%) |
Sep 2012 | - | $6.29 M(+51.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2012 | - | $4.16 M(-44.9%) |
Mar 2012 | - | $7.54 M(-15.3%) |
Dec 2011 | $8.90 M(-14.8%) | $8.90 M(+26.5%) |
Sep 2011 | - | $7.03 M(+28.2%) |
Jun 2011 | - | $5.49 M(+13.6%) |
Mar 2011 | - | $4.83 M(-53.7%) |
Dec 2010 | $10.44 M(+25.9%) | $10.44 M(-14.0%) |
Sep 2010 | - | $12.14 M(-42.9%) |
Jun 2010 | - | $21.27 M(+502.8%) |
Mar 2010 | - | $3.53 M(-57.4%) |
Dec 2009 | $8.29 M(-71.9%) | $8.29 M(-53.8%) |
Sep 2009 | - | $17.93 M(+78.9%) |
Jun 2009 | - | $10.02 M(-57.3%) |
Mar 2009 | - | $23.46 M(-20.3%) |
Dec 2008 | $29.45 M(-21.7%) | $29.45 M(+27.6%) |
Sep 2008 | - | $23.09 M(-26.6%) |
Jun 2008 | - | $31.45 M(-7.3%) |
Mar 2008 | - | $33.91 M(-9.8%) |
Dec 2007 | $37.59 M(-9.5%) | $37.59 M(+4.3%) |
Sep 2007 | - | $36.03 M(+11.8%) |
Jun 2007 | - | $32.23 M(-3.5%) |
Mar 2007 | - | $33.39 M(-19.7%) |
Dec 2006 | $41.55 M(-36.6%) | $41.55 M(+10.2%) |
Sep 2006 | - | $37.72 M(-8.6%) |
Jun 2006 | - | $41.25 M(-6.4%) |
Mar 2006 | - | $44.09 M(-32.7%) |
Dec 2005 | $65.54 M(+227.2%) | $65.54 M(+126.7%) |
Sep 2005 | - | $28.91 M(-4.5%) |
Jun 2005 | - | $30.27 M(+63.9%) |
Mar 2005 | - | $18.47 M(-7.8%) |
Dec 2004 | $20.03 M(-5.5%) | $20.03 M(+9.8%) |
Sep 2004 | - | $18.25 M(+137.6%) |
Jun 2004 | - | $7.68 M(-64.6%) |
Mar 2004 | - | $21.67 M(+2.2%) |
Dec 2003 | $21.20 M(+50.5%) | $21.20 M(-18.4%) |
Sep 2003 | - | $25.98 M(-29.5%) |
Jun 2003 | - | $36.84 M(+127.3%) |
Mar 2003 | - | $16.21 M(+15.1%) |
Dec 2002 | $14.09 M(+11.9%) | $14.09 M(-22.7%) |
Sep 2002 | - | $18.23 M(+147.1%) |
Jun 2002 | - | $7.38 M(-54.2%) |
Mar 2002 | - | $16.11 M(+27.9%) |
Dec 2001 | $12.60 M(-73.0%) | $12.60 M(-39.9%) |
Sep 2001 | - | $20.97 M(-41.1%) |
Jun 2001 | - | $35.62 M(-25.1%) |
Mar 2001 | - | $47.56 M(+1.8%) |
Dec 2000 | $46.70 M(+1109.0%) | $46.70 M(+141.7%) |
Sep 2000 | - | $19.32 M(-23.3%) |
Jun 2000 | - | $25.18 M |
Dec 1999 | $3.86 M | - |
FAQ
- What is DURECT annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for DURECT?
- What is DURECT annual cash & cash equivalents year-on-year change?
- What is DURECT quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for DURECT?
- What is DURECT quarterly cash and cash equivalents year-on-year change?
What is DURECT annual cash & cash equivalents?
The current annual cash & cash equivalents of DRRX is $28.40 M
What is the all time high annual cash & cash equivalents for DURECT?
DURECT all-time high annual cash & cash equivalents is $65.54 M
What is DURECT annual cash & cash equivalents year-on-year change?
Over the past year, DRRX annual cash & cash equivalents has changed by -$15.08 M (-34.69%)
What is DURECT quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DRRX is $9.09 M
What is the all time high quarterly cash and cash equivalents for DURECT?
DURECT all-time high quarterly cash and cash equivalents is $65.54 M
What is DURECT quarterly cash and cash equivalents year-on-year change?
Over the past year, DRRX quarterly cash and cash equivalents has changed by -$29.90 M (-76.69%)